MASLD is prevalent in T2DM patients, with a 65% occurrence rate, and poses a higher risk for severe liver diseases. The study analyzed 3,836 T2DM patients, identifying key predictors like BMI, ...
DALLAS--(BUSINESS WIRE)--CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — today announced PropheSee ™ a new, AI-powered ...
Medicine has always operated as an “evidence based” field, meaning that it generally pursues experimentation to gather ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results